Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Clinical trial NCT06126380 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06126380
- Sponsor
- Eledon Pharmaceuticals
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2029-12-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.